2026-03-11 — ADHD medication evidence, long-term monitoring, safety (5 cards)
ADHD medication evidence spans first-line choice, long-term monitoring, evidence certainty, misconceptions, and combined care. Keep each card tied to its original source record.
Result: Methylphenidate was supported as the first-line choice for children and adolescents.
Result: Small reductions in height (~1.4 cm) and weight (~2.0 kg) were observed, with recovery trends in many cases.
Result: This means "hard to say with certainty," not "it doesn't work."
Result: When taken as prescribed, subsequent SUD risk was not increased.
Result: All medications significantly improved QoL, but effect sizes were smaller than symptom reduction.
Existing 2026-03-11 detail paths and source href/token values are preserved. This screen is the PRO-library entry point for the five existing English card details.
Result: Methylphenidate was supported as the first-line choice for children and adolescents.
Result: Small reductions in height (~1.4 cm) and weight (~2.0 kg) were observed, with recovery trends in many cases.
Result: This means "hard to say with certainty," not "it doesn't work."
Result: When taken as prescribed, subsequent SUD risk was not increased.
Result: All medications significantly improved QoL, but effect sizes were smaller than symptom reduction.
Medication evidence cards do not replace diagnosis or medication decisions; they help prepare questions before professional consultation.
Confirmed source href/token values are kept from the existing English details.